Sign in

CIK 0001101026

  • Non-accelerated filer
  • Smaller reporting company

Zivo Bioscience, Inc.

Sign in to watch
Ticker
ZIVO
Exchange
OTC
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
NV
Entity type
Operating
EIN
870699977
Phone
+1 248-452-9866
Business address
21 E. LONG LAKE ROAD, SUITE 100, BLOOMFIELD HILLS, MI, 48304
Former names
HEALTH ENHANCEMENT PRODUCTS INC, WESTERN GLORY HOLE INC
  1. 4 Open-market buy 10% owner bought 50,600 shares at an average $0.24 ($12,106)
  2. 4 Open-market buy 10% owner bought 87,500 shares at an average $0.27 ($23,519)
  3. 4 Open-market buy 10% owner bought 201,125 shares at an average $0.26 ($51,396)
  4. 4 Open-market buy 10% owner bought 16,000 shares at $0.25 ($4,016)
  5. 4 Open-market buy 10% owner bought 18,500 shares at $0.25 ($4,562)
  6. 4 Open-market buy 10% owner bought 52,500 shares at $0.26 ($13,855)
  7. 4 Open-market buy 10% owner bought 60,000 shares at $0.26 ($15,744)
  8. 4 Open-market buy 10% owner bought 37,500 shares at $0.28 ($10,680)
  9. 4 Open-market buy 10% owner bought 163,000 shares at an average $0.27 ($44,622)
  10. 3/A Insider 3/A
  11. 3 Insider Initial Statement of Ownership
  12. 4 Open-market buy President/CEO bought 5,000 shares at $0.11 ($542)
  13. 4 Open-market buy President/CEO bought 95,000 shares at $0.11 ($10,289)
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Grant or award President, CEO acquired 1,458,232 shares (grant or award)
  19. 3 Insider Initial Statement of Ownership
  20. 3 Insider Initial Statement of Ownership

Page 10 of 12 · 239 filings